SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022592
Filing Date
2019-11-13
Accepted
2019-11-13 08:01:15
Documents
49
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20190930_10q.htm 10-Q 610003
2 EXHIBIT 31.1 ex_162921.htm EX-31.1 10608
3 EXHIBIT 31.2 ex_162922.htm EX-31.2 10597
4 EXHIBIT 32.1 ex_162923.htm EX-32.1 4603
5 EXHIBIT 32.2 ex_162924.htm EX-32.2 4936
  Complete submission text file 0001437749-19-022592.txt   2959850

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snbp-20190930.xml EX-101.INS 485085
7 XBRL TAXONOMY EXTENSION SCHEMA snbp-20190930.xsd EX-101.SCH 34158
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20190930_cal.xml EX-101.CAL 25176
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20190930_def.xml EX-101.DEF 239031
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20190930_lab.xml EX-101.LAB 208319
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20190930_pre.xml EX-101.PRE 257478
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 191211719
SIC: 2834 Pharmaceutical Preparations